J, H., E, T., X, C., M, F., & C, B. (2023). Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure. ESC heart failure, 10(1), 66. https://doi.org/10.1002/ehf2.14137
Chicago Style (17th ed.) CitationJ, Henrysson, Thunström E, Chen X, Fu M, and Basic C. "Hyperkalaemia as a Cause of Undertreatment with Mineralocorticoid Receptor Antagonists in Heart Failure." ESC Heart Failure 10, no. 1 (2023): 66. https://doi.org/10.1002/ehf2.14137.
MLA (9th ed.) CitationJ, Henrysson, et al. "Hyperkalaemia as a Cause of Undertreatment with Mineralocorticoid Receptor Antagonists in Heart Failure." ESC Heart Failure, vol. 10, no. 1, 2023, p. 66, https://doi.org/10.1002/ehf2.14137.
Warning: These citations may not always be 100% accurate.